PARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development, ahead of the start of this year's annual 'Choose France' business summit. ($1 = 0.9286 euros) (Reporting by Sudip Kar-Gupta and Elizabeth Pineau; Editing by Hugh Lawson)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.1 USD | -1.71% | +0.45% | +0.90% |
03:34pm | Pfizer: initiative against antibiotic resistance in Malawi | CF |
03:28pm | The market is good to go until Nvidia’s next quarterly results |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.90% | 17TCr | |
+38.89% | 72TCr | |
+34.21% | 59TCr | |
-2.92% | 37TCr | |
+19.78% | 33TCr | |
+2.01% | 28TCr | |
+16.96% | 24TCr | |
+9.50% | 21TCr | |
-4.99% | 21TCr | |
+6.32% | 17TCr |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer announces 500 million euros investment in France